FDA
- Status: approved
Hematological Stem Cell Transplantation (Hematological Stem Cell Transplantation) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Rambam Health Care Campus is the originator. The local marketing authorisation holder may differ — check the official source linked above.